Page 433 - The Case Lab Book
P. 433

He added: "The gap between our offer and Barclays was almost exactly the same as the day we launched the bid all
               those months ago."

               exceeded only by its £21bn purchase of National Westminster in 2000.

               Royal's shares closed at 674.5p on April 13 this year - just before the bank confirmed it was involved in a consortium
               bid for ABN. They closed last night at 559p 10 Oct 2007.

               As well as the general downward pressure on the share price of any company which is to issue shares to fund a big
               takeover, UK banking stocks as a whole have been hit hard by the global credit market crisis. This crisis, which
               started with massive default by those US homeowners with poorer credit ratings served by the sub-prime mortgage
               sector, eventually triggered a run on UK bank Northern Rock.

               Asked by The Herald if he was happy with Royal's share-price performance, under the circumstances, Goodwin
               replied: "The share price has held up very well through a very difficult time in the market for financial stocks. I would
               like to, and fully intend to, see our share price considerably higher than where it is today."

               Goodwin declared "cash is always king" and noted it was "even more fortuitous" in this instance given the unforeseen
               hit on banking stocks from the credit crisis.

               He insisted, meanwhile, that the ultimate success of the ABN deal was not dependent on a recovery of capital
               markets from recent turbulence.

               Goodwin said: "A lot of the businesses we are acquiring are about doing day-to-day transactions for businesses and
               are not as highly leveraged to capital markets as you might think."

               Under the consortium's original bid, Royal would have taken ABN's US subsidiary, LaSalle. However, in what was
               viewed widely as a poison pill deal aimed at warding off the consortium and aiding Barclays, ABN agreed to sell
               LaSalle to Bank of America for $21bn. After a lengthy Dutch court battle, following a challenge to this deal mounted
               by ABN investors, the sale of LaSalle to Bank of America was allowed to go ahead. Goodwin said yesterday: "The
               transaction stands up strongly without LaSalle. It is a pity we didn't get LaSalle. It really feels like ancient history now.
               It is no use crying over spilt milk."



               Barclay

               Barclays was expected to keep the bank largely intact.


               Nevertheless, the failure to pull off the deal - Europe's largest banking takeover - will
               inevitably raise question marks about Barclays' future.


               The loss of the bid has been both good and bad news for Barclays. On the one hand it cuts short
               the growth it hoped to achieve through the acquisition, including in emerging markets such as
               Brazil. The very public airing of differences between shareholders and management has also hurt
               the reputation of Barclays' Chief Executive John Varley.


               At the same time, Barclays shareholders have voiced their concerns about taking on a massive
               bank that was less profitable than their own. Chen said that while Barclays offers a 12% return
               on investment, ABN Amro offers only 9.0%.
   428   429   430   431   432   433   434   435   436   437   438